Vítor Campos

Dr. Vítor Campos

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2025 in Health Information Science and Systems
Verified
Journal Article
Open access
PDF file
VCVítor Campos
Vítor Campos
TPTiago Paiva Prudente
Tiago Paiva Prudente
LLLuana Lemos Leão
Luana Lemos Leão
MCMaurício Silva da Costa
Maurício Silva da Costa
Henrique Nunes Pereira OlivaHenrique Nunes Pereira Oliva
Henrique Nunes Pereira Oliva
RMRenato Sobral Monteiro-Junior
Renato Sobral Monteiro-Junior
Purpose Large-language models (LLMs) are increasingly used for health advice, but their alignment with evidence-based guidelines and sensitivity to question phrasing remain unclear. Methods In May 2025, we evaluated ChatGPT 4.0, ChatGPT 4.5, and DeepSeek V3 using four clinical vignettes: major depression with polysubstance use, irritable bowel syndrome flare, new-onset hypertension requiring exercise counseling, and chronic low back pain. Each scenario was tested with clinician- and patient-style prompts, generating 24 responses. Outputs were benchmarked against 89 guideline-derived recommendations from three authoritative sources per domain. Two blinded reviewers scored concordance (1 = actionable detail, 0.5 = generic mention, 0 = absent), with adjudication by a third reviewer. Inter-rater reliability was measured using Cronbach’s α. Results ChatGPT 4.5 achieved the highest guideline concordance (61.9%), followed by DeepSeek V3 (60.7%) and ChatGPT 4.0 (53.7%). Performance varied by domain, exceeding 67% in mental health but dropping below 45% in nutrition. Prompt phrasing influenced capture rates, with clinician-style prompts improving scores in exercise and pain domains, while patient-style prompts outperformed in nutrition. Reviewer agreement was high (α = 0.97 for chatbot scoring; 0.80 for matrix coding). Conclusion LLMs can rapidly generate draft care plans that reflect clinical guidelines, though they favor generic over individualized advice. By introducing a unique, domain-agnostic scoring rubric that aligns AI-generated 30-day care plans with gold-standard guidelines, and by applying it in parallel to mental health, nutrition, exercise, and physical therapy scenarios, our study delivers the first prompt-sensitive audit showing where current LLMs exceed, match, or fall short of multidisciplinary best practices.

18 July 2025 in Biochem
Verified
Journal Article
Open access
PDF file
VCVítor Campos
Vítor Campos
AYAngela Theresa Zuffo Yabrude
Angela Theresa Zuffo Yabrude
RLRenata Delarue Toniolo Lima
Renata Delarue Toniolo Lima
FWFernanda Wagner
Fernanda Wagner
Henrique Nunes Pereira OlivaHenrique Nunes Pereira Oliva
Henrique Nunes Pereira Oliva
Background/Objectives: Passiflora (passionflower), traditionally used for anxiety and insomnia, is primarily known for GABAergic modulation. However, evidence suggests broader neuropharmacological actions. This review aimed to systematically explore non-GABAergic mechanisms of Passiflora. Methods: We performed a systematic review following PRISMA Guidelines (PROSPERO: CRD420251028681). PubMed/Medline, PsycINFO, Embase, Web of Science, and Scopus were searched for original research on non-GABA neurobiological mechanisms of Passiflora species (P. incarnata, P. edulis, P. caerulea, P. actinia, P. foetida). Studies were screened and assessed for eligibility, and data on design, Passiflora preparation, mechanisms, and main findings were extracted. Results: Thirteen studies revealed diverse non-GABAergic actions. Passiflora modulates opioidergic and nicotinic cholinergic systems (relevant to analgesia), monoaminergic pathways (affecting dopamine, norepinephrine, serotonin), and the glutamatergic system (offering neuroprotection via NMDA receptor inhibition). It also exhibits significant anti-inflammatory and antioxidant effects (reducing cytokines, activating Nrf2) and modulates the HPA axis (reducing stress hormones). Other mechanisms include gut microbiota modulation and metabolic effects. Conclusions: Passiflora’s therapeutic potential extends beyond GABA, involving multiple neurotransmitter systems and neuroprotective, anti-inflammatory, antioxidant, and HPA axis-regulating activities. This multi-target profile likely contributes to its clinical efficacy in conditions like anxiety, pain, and stress, potentially with a favorable side-effect profile. Further research, including mechanistic studies and clinical trials with relevant biomarkers, is needed to fully elucidate its complex pharmacology.

4 November 2025 in The American Journal on Addictions
Verified
Journal Article
Closed access
VCVítor Campos
Vítor Campos
DHDaniel L. Heringer
Daniel L. Heringer
GCGabriel P. A. Costa
Gabriel P. A. Costa
Henrique Nunes Pereira OlivaHenrique Nunes Pereira Oliva
Henrique Nunes Pereira Oliva
AAAkhil Anand
Akhil Anand